IDEX (IEX) AI Stock Analysis

• Market Cap: $14.26B
• Dividend Yield: 1.56%
• Average Volume (3M): 535.84K
• Price to Earnings (P/E): 30.1
• Beta (1Y): 1.00
• Revenue Growth: 7.09%
• EPS Growth: -2.29%
• Country: US
• Employees: 9,000
• Sector: Industrials
• Sector Strength: 72
• Industry: Industrial - Machinery
• EPS (TTM): 2.03
• Shares Outstanding: 74,849,434
• 10 Day Avg. Volume: 435,913
• 30 Day Avg. Volume: 535,842
• PEG Ratio: -2.04
• Price to Book (P/B): 4.18
• Price to Sales (P/S): 4.85
• P/FCF Ratio: 26.27
• Enterprise Value/Market Cap: 0.95
• Enterprise Value/Revenue: 3.97
• Enterprise Value/Gross Profit: 9.13
• Enterprise Value/Ebitda: 15.34
• 1Y Price Target: $193.83
• Price Target Upside: 1.73% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 6
• EPS Forecast (FY): 8.3
• Revenue Forecast (FY): $3.54B

• Rating: 75 Outperform
• Price Target: $198.00 ▲(3.92% Upside)

IDEX's strong financial performance and positive earnings call results are the most significant factors driving the score. The technical analysis supports a bullish outlook, though the high valuation suggests some caution. The company's strategic focus on growth and shareholder returns further enhances its position.

Positive Factors

Revenue Growth

The consistent growth in organic orders and sales indicates strong demand for IDEX's products, supporting long-term revenue expansion and market position.

Strategic Acquisitions

Successful integration of acquisitions enhances IDEX's competitive edge and market reach, driving sustainable growth and profitability.

Leadership Change

The appointment of a new CFO with extensive experience is expected to strengthen IDEX's financial strategy and support long-term growth initiatives.

Negative Factors

Declining Free Cash Flow

A significant decline in free cash flow growth can limit IDEX's ability to invest in new opportunities and maintain financial flexibility.

Margin Compression

Margin compression may indicate rising costs or pricing pressures, potentially impacting profitability and operational efficiency over time.

Macroeconomic Challenges

Ongoing macroeconomic challenges could hinder growth in certain segments, affecting overall performance and strategic execution.

IDEX Business Overview & Revenue Model

Company Description

IDEX Corporation, together with its subsidiaries, provides applied solutions worldwide. The company operates through three segments: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT segment designs, produces, and distributes positive displacement pumps, small volume provers, flow meters, injectors, and other fluid-handling pump modules and systems, as well as offers flow monitoring and other services for the food, chemical, general industrial, water and wastewater, agricultural, and energy industries. The HST segment designs, produces, and distributes precision fluidics, rotary lobe pumps, centrifugal and positive displacement pumps, roll compaction and drying systems, pneumatic components and sealing solutions, high performance molded and extruded sealing components, custom mechanical and shaft seals, engineered hygienic mixers and valves, biocompatible medical devices and implantables, air compressors and blowers, optical components and coatings, laboratory and commercial equipment, precision photonic solutions, and precision gear and peristaltic pump technologies. This segment serves food and beverage, pharmaceutical and biopharmaceutical, cosmetics, marine, chemical, wastewater and water treatment, life sciences, research, and defense markets. The FSDP segment designs, produces, and distributes firefighting pumps, valves and controls, rescue tools, lifting bags, and other components and systems for the fire and rescue industry; engineered stainless steel banding and clamping devices for various industrial and commercial applications; and precision equipment for dispensing, metering, and mixing colorants and paints used in retail and commercial businesses. IDEX Corporation was incorporated in 1987 and is headquartered in Northbrook, Illinois.

How the Company Makes Money

IDEX generates revenue primarily through the sale of its products and services across multiple sectors. Its key revenue streams include the sale of precision instruments and components, as well as maintenance and support services for its equipment. The company benefits from a diversified client base, including healthcare providers, industrial manufacturers, and energy companies, which helps mitigate risks associated with market fluctuations. Additionally, IDEX has established significant partnerships and collaborations with leading organizations in various industries, enhancing its market reach and driving sales growth. The company's focus on innovation and product development further contributes to its revenue by allowing it to introduce new solutions that meet evolving customer needs.

IDEX Financial Statement Overview

Summary

IDEX demonstrates solid financial health with consistent revenue growth and strong operational margins. The balance sheet is stable with low leverage, and cash flows are generally healthy despite recent declines in free cash flow. Continued focus on cost management and cash flow improvement will be crucial for sustaining growth.

Income Statement

IDEX shows consistent revenue growth with a TTM increase of 2.41%, despite a slight decline in gross and net profit margins compared to previous years. The EBIT and EBITDA margins remain strong, indicating operational efficiency. However, the slight decrease in net income suggests potential cost pressures.

Balance Sheet

The company maintains a healthy balance sheet with a low debt-to-equity ratio of 0.47 in the TTM, indicating strong financial stability. Return on Equity (ROE) is solid at 12.16%, reflecting effective use of equity. The equity ratio is robust, showcasing a strong asset base relative to liabilities.

Cash Flow

Operating cash flow remains strong with a coverage ratio of 1.14, indicating good cash generation relative to net income. However, the negative free cash flow growth rate of -49.4% in the TTM is a concern, suggesting potential cash management issues or increased capital expenditures.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	3.42B	3.27B	3.27B	3.18B	2.76B	2.35B
Gross Profit	1.49B	1.52B	1.62B	1.59B	1.36B	1.16B
EBITDA	884.70M	859.40M	964.10M	909.80M	720.50M	604.60M
Net Income	478.10M	505.00M	596.10M	586.90M	449.40M	377.80M
Balance Sheet
Total Assets	6.97B	6.75B	5.87B	5.51B	4.92B	4.41B
Cash, Cash Equivalents and Short-Term Investments	593.80M	620.80M	534.30M	430.20M	900.70M	1.03B
Total Debt	1.90B	1.99B	1.45B	1.59B	1.30B	1.16B
Total Liabilities	2.96B	2.95B	2.32B	2.47B	2.11B	1.87B
Stockholders Equity	4.01B	3.79B	3.54B	3.04B	2.80B	2.54B
Cash Flow
Free Cash Flow	584.10M	603.00M	626.80M	489.40M	492.60M	517.70M
Operating Cash Flow	643.50M	668.10M	716.70M	557.40M	565.30M	569.30M
Investing Cash Flow	-134.70M	-1.01B	-283.80M	-917.20M	-698.10M	-172.60M
Financing Cash Flow	-565.70M	465.90M	-344.70M	-37.80M	-9.50M	-42.60M

IDEX Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 190.54
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IEX, the sentiment is Positive. The current price of 190.54 is above the 20-day moving average (MA) of 181.21, above the 50-day MA of 175.26, and above the 200-day MA of 172.03, indicating a bullish trend. The MACD of 3.33 indicates Negative momentum. The RSI at 72.76 is Negative, neither overbought nor oversold. The STOCH value of 94.90 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IEX.

IDEX Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
NDSN	79 Outperform	$14.88B	31.31	16.21%	1.64%	3.78%	4.85%
GGG	78 Outperform	$14.37B	29.62	19.45%	1.32%	2.85%	3.09%
IEX	75 Outperform	$14.26B	30.12	12.21%	1.56%	7.09%	-2.29%
ITT	72 Outperform	$15.57B	30.07	17.85%	0.79%	8.01%	2.67%
CR	70 Outperform	$11.70B	36.72	18.09%	0.49%	-0.37%	21.77%
Sector *	63 Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%
GNRC	59 Neutral	$9.40B	30.73	12.38%	―	5.52%	9.03%

IDEX Corporate Events

IDEX Appoints New CFO Amid Leadership Changes

On December 4, 2025, IDEX Corporation announced the appointment of Sean M. Gillen as Senior Vice President and Chief Financial Officer, effective January 5, 2026. Gillen, with extensive experience in financial performance and strategic growth, previously served as CFO at AAR CORP. His appointment is expected to bolster IDEX’s enterprise strategy and growth across key sectors. Concurrently, Melissa S. Flores, Senior Vice President and Chief Human Resources Officer, will depart on December 19, 2025, with IDEX planning to fill the role externally to enhance its talent strategy and culture.

The most recent analyst rating on (IEX) stock is a Buy with a $200.00 price target. To see the full list of analyst forecasts on IDEX stock, see the IEX Stock Forecast page.